Related references
Note: Only part of the references are listed.Gene Therapy for Immunodeficiency Due to Adenosine Deaminase Deficiency.
Alessandro Aiuti et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Cognitive and behavioral abnormalities in children after hematopoietic stem cell transplantation for severe congenital immunodeficiencies
Penny Titman et al.
BLOOD (2008)
Neonatal bone marrow transplantation of ADA-deficient SCID mice results in immunologic reconstitution despite low levels of engraftment and an absence of selective donor T lymphoid expansion
Denise A. Carbonaro et al.
BLOOD (2008)
Altered intracellular and extracellular signaling leads to impaired T-cell functions in ADA-SCID patients
Barbara Cassani et al.
BLOOD (2008)
Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients
Steven J. Howe et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Gene therapy for childhood immunological diseases
D. B. Kohn
BONE MARROW TRANSPLANTATION (2008)
Multilineage hematopoietic reconstitution without clonal selection in ADA-SCID patients treated with stem cell gene therapy
Alessandro Aiuti et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Burkitt's lymphoma in a patient with adenosine deaminase deficiency-severe combined immunodeficiency treated with polyethylene glycol-adenosine deaminase
Maitham Husain et al.
JOURNAL OF PEDIATRICS (2007)
Management options for adenosine deaminase deficiency; proceedings of the EBMT satellite workshop (Hamburg, March 2006)
Claire Booth et al.
CLINICAL IMMUNOLOGY (2007)
Patients with adenosine deaminase deficiency surviving after hematopoietic stem cell transplantation are at high risk of CNS complications
Manfred Hoenig et al.
BLOOD (2007)
Prolonged pancytopenia in a gene therapy patient with ADA-deficient SCID and trisomy 8 mosaicism: a case report
Barbara C. Engel et al.
BLOOD (2007)
Ex vivo gene therapy with lentiviral vectors rescues adenosine deaminase (ADA)-deficient mice and corrects their immune and metabolic defects
Alessandra Mortellaro et al.
BLOOD (2006)
Successful reconstitution of immunity in ADA-SCID by stem cell gene therapy following cessation of PEG-ADA and use of mild preconditioning
H. Bobby Gaspar et al.
MOLECULAR THERAPY (2006)
Bone marrow transplantation for severe combined immune deficiency
E Grunebaum et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Cerebral lymphoma in an adenosine deaminase-deficient patient with severe combined immunodeficiency receiving polyethylene glycol-conjugated adenosine deaminase
DA Kaufman et al.
PEDIATRICS (2005)
Reduced thymic output, increased spontaneous apoptosis and oligoclonal B cells in polyethylene glycol-adenosine deaminase-treated patients
F Malacarne et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2005)
Long-term efficacy of enzyme replacement therapy for Adenosine deaminase (ADA)-deficient Severe Combined Immunodeficiency (SCID)
B Chan et al.
CLINICAL IMMUNOLOGY (2005)
Clonal evidence for the transduction of CD34+ cells with lymphomyeloid differentiation potential and self-renewal capacity in the SCID-X1 gene therapy trial
M Schmidt et al.
BLOOD (2005)
Severe combined immunodeficiency.: A model disease for molecular immunology and therapy
A Fischer et al.
IMMUNOLOGICAL REVIEWS (2005)
Bilateral sensorineural deafness in adenosine deaminase-deficient severe combined immunodeficiency
W Albuquerque et al.
JOURNAL OF PEDIATRICS (2004)
LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1
S Hacein-Bey-Abina et al.
SCIENCE (2003)
A1 adenosine receptors mediate hypoxia-induced ventriculomegaly
CP Turner et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Persistence and expression of the adenosine deaminase gene for 12 years and immune reaction to gene transfer components: long-term results of the first clinical gene therapy trial
LM Muul et al.
BLOOD (2003)
Long-term survival and transplantation of haemopoietic stem cells for immunodeficiencies:: report of the European experience 1968-99
C Antoine et al.
LANCET (2003)
Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning
A Aiuti et al.
SCIENCE (2002)
Immune reconstitution in ADA-SCID after PBL gene therapy and discontinuation of enzyme replacement
A Aiuti et al.
NATURE MEDICINE (2002)
Cognitive and behavioral abnormalities in adenosine deaminase deficient severe combined immunodeficiency
MH Rogers et al.
JOURNAL OF PEDIATRICS (2001)
Adenosine deaminase deficiency increases thymic apoptosis and causes defective T cell receptor signaling
SG Apasov et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)
Share Paper
